Preemptive therapy for cytomegalovirus.
Singh
Nina
N
Yu
Victor L
VL
D000998:Antiviral Agents / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000517:prevention & control*; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000821:virology; D006085:Graft Survival; D006801:Humans; D016867:Immunocompromised Host; D016031:Liver Transplantation / Q000009:adverse effects* / Q000276:immunology; D008297:Male; D009894:Opportunistic Infections / Q000188:drug therapy / Q000517:prevention & control*; D011300:Preoperative Care; D011322:Primary Prevention / Q000379:methods; D018570:Risk Assessment; D014181:Transplantation Immunology; D016896:Treatment Outcome
D000998:Antiviral Agents